Literature DB >> 27058511

Salmonella flagellin acted as an effective fusion partner for expression of Plasmodium falciparum surface protein 25 in Escherichia coli.

Feng Qian1, Mengmeng Li1, Yong Chen2, Lin Jiang2, Huji Xu1.   

Abstract

Plasmodium falciparum surface protein 25 (Pfs25) is a hard-to-express and hard-to-solubilize protein in Escherichia coli. To overcome this problem, the phase 1 flagellin of Salmonella enterica serovar Typhimurium (FliC) was used as a fusion partner for Pfs25. The fusion expression of Pfs25 with FliC greatly enhanced the expression level and solubility of Pfs25 in E. coli BL21(DE3). The Ni-purified fusion protein of FliC-Pfs25 was recognized by two anti-Pfs25 monoclonal antibodies. By comparison, it was shown that the Pfs25 within FliC-Pfs25 contained epitopes similar or identical to those on Pichia pastoris-produced Pfs25. The data obtained from this study demonstrated that the fusion with Salmonella flagellin greatly improved the expression of Pfs25 in E. coli.

Entities:  

Keywords:  Escherichia coli; Fusion partner; Pfs25; Plasmodium falciparum; Salmonella flagellin

Mesh:

Substances:

Year:  2016        PMID: 27058511      PMCID: PMC5027733          DOI: 10.1080/21645515.2016.1171443

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  10 in total

Review 1.  Tagging recombinant proteins to enhance solubility and aid purification.

Authors:  Dermot Walls; Sinéad T Loughran
Journal:  Methods Mol Biol       Date:  2011

Review 2.  Flagellin as an adjuvant: cellular mechanisms and potential.

Authors:  Steven B Mizel; John T Bates
Journal:  J Immunol       Date:  2010-11-15       Impact factor: 5.422

3.  Salmonella flagellin is a potent carrier-adjuvant for peptide conjugate to induce peptide-specific antibody response in mice.

Authors:  Feng Qian; Aihua Guo; Mengmeng Li; Wei Liu; Zhiming Pan; Lei Jiang; Xin Wu; Huji Xu
Journal:  Vaccine       Date:  2015-03-10       Impact factor: 3.641

4.  The IC(50) of anti-Pfs25 antibody in membrane-feeding assay varies among species.

Authors:  Lediya Cheru; Yimin Wu; Ababacar Diouf; Samuel E Moretz; Olga V Muratova; Guanhong Song; Michael P Fay; Louis H Miller; Carole A Long; Kazutoyo Miura
Journal:  Vaccine       Date:  2010-04-29       Impact factor: 3.641

5.  Overproduction of Pichia pastoris or Plasmodium falciparum protein disulfide isomerase affects expression, folding and O-linked glycosylation of a malaria vaccine candidate expressed in P. pastoris.

Authors:  Chiawei W Tsai; Peter F Duggan; Richard L Shimp; Louis H Miller; David L Narum
Journal:  J Biotechnol       Date:  2005-11-07       Impact factor: 3.307

6.  Saccharomyces cerevisiae recombinant Pfs25 adsorbed to alum elicits antibodies that block transmission of Plasmodium falciparum.

Authors:  D C Kaslow; I C Bathurst; T Lensen; T Ponnudurai; P J Barr; D B Keister
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

7.  Potent malaria transmission-blocking antibody responses elicited by Plasmodium falciparum Pfs25 expressed in Escherichia coli after successful protein refolding.

Authors:  Rajesh Kumar; Evelina Angov; Nirbhay Kumar
Journal:  Infect Immun       Date:  2014-01-13       Impact factor: 3.441

8.  A vaccine candidate from the sexual stage of human malaria that contains EGF-like domains.

Authors:  D C Kaslow; I A Quakyi; C Syin; M G Raum; D B Keister; J E Coligan; T F McCutchan; L H Miller
Journal:  Nature       Date:  1988-05-05       Impact factor: 49.962

9.  Expression of malaria transmission-blocking vaccine antigen Pfs25 in Pichia pastoris for use in human clinical trials.

Authors:  Lanling Zou; Aaron P Miles; Jin Wang; Anthony W Stowers
Journal:  Vaccine       Date:  2003-04-02       Impact factor: 3.641

Review 10.  Fusion tags for protein solubility, purification and immunogenicity in Escherichia coli: the novel Fh8 system.

Authors:  Sofia Costa; André Almeida; António Castro; Lucília Domingues
Journal:  Front Microbiol       Date:  2014-02-19       Impact factor: 5.640

  10 in total
  1 in total

1.  Fusion to Tetrahymena thermophila granule lattice protein 1 confers solubility to sexual stage malaria antigens in Escherichia coli.

Authors:  Alka Agrawal; Yelena Bisharyan; Ashot Papoyan; Janna Bednenko; Joanna Cardarelli; Monica Yao; Theodore Clark; Mehmet Berkmen; Na Ke; Paul Colussi
Journal:  Protein Expr Purif       Date:  2018-08-03       Impact factor: 1.650

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.